Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyMarline G. Harmsen, Joanne A. de Hullu, Marian J.E. Mourits et al.|BMC Cancer|2015Cited by 106
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1/2</i> Pathogenic Variant CarriersMiranda P. Steenbeek, Joanne A. de Hullu, Marline G. Harmsen et al.|JAMA Oncology|2021Cited by 78
Peritoneal carcinomatosis after risk‐reducing surgery in <i>BRCA1/2</i> mutation carriersMarline G. Harmsen, Joanne A. de Hullu, Jurgen M.J. Piek et al.|Cancer|2018Cited by 40
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H.D. van Bommel, Joanne A. de Hullu, Miranda P. Steenbeek et al.|Supportive Care in Cancer|2022Cited by 9
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P. Steenbeek, Rosella Hermens, Majke H.D. van Bommel et al.|Gynecologic Oncology|2021Cited by 6